Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP
The Long Read: These days, both the tools and data are available to develop models for creating significant value from corporate IP assets. All too often, though, what is still missing is the will to use them. Jeremiah Chan and Jonathan Liu of Facebook and Cipher’s Nigel Swycher and Steve Harris argue that a change of mindset among portfolio managers could reap significant rewards Read more
Saturday Opinion: Encouraging patent deals and lending through metrics and incentives could lay a trap for those who want a higher-quality patent system Read more
The state-backed patent funds helped change the culture around patents in the South Korea and Japan, and now both face the task of surviving the private sector Read more
Many court dockets are on hold, but IP disputes are not. Ocean Tomo and the International Arbitration Centre Tokyo think ADR can help bridge the gap Read more
A year after a major capital infusion and a change of leadership, the firm has notched some notable settlements in the US and laid the groundwork for new assertion campaigns Read more
A recent report suggests Wall Street is beginning to realise that the rise of intangible assets has thrown a spanner into time-tested valuation models Read more
